Precision glycoengineered AAV capsids enhance hepatocyte targeting and attenuated immune activation for liver-directed gene therapy

Authors:

Abstract
No abstract available
Funding Information
  • National Natural Science Foundation of China (91753202)
  • National Natural Science Foundation of China (82130100)
  • National Natural Science Foundation of China (32370156)
  • National Natural Science Foundation of China (82173724)
  • National Key Research and Development Program of China (2024YFA0917500)

This publication has 106 references indexed in Scilit: